Disease · HP_0000708
Trials15
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 1 more is not shown, since the checks do not confirm it.
1 to 15 of 15
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00584701 | Pharmacogenomics in Autism Treatment | Phase 2/3 | 49 | 2012-07-24 | Autism | RISPERIDONE | Its record names the disease | ClinicalTrials.gov |
| NCT04292457 | Namsos Anaesthesia Children Outcome Study | Not applicable | 761 | Emergence Delirium | PROPOFOL, SEVOFLURANE | Its record names the disease | ClinicalTrials.gov | |
| NCT01021696 | Pain in Patients With Dementia and Behavioural Disturbances | Phase 2/3 | 352 | Dementia, Pain, Agitation | ACETAMINOPHEN, BUPRENORPHINE, MORPHINE, PREGABALIN | Its record names the disease | ClinicalTrials.gov | |
| NCT00249145 | A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia | Phase 3 | 349 | Dementia, Alzheimer Disease, Dementia, Vascular | RISPERIDONE | Its record names the disease | ClinicalTrials.gov | |
| NCT02956226 | Cannabinoids for Behavioral Problems in Children With ASD | Phase 2 | 150 | Autistic Disorder | CANNABIDIOL, DRONABINOL | Its record names the disease | ClinicalTrials.gov | |
| NCT03862950 | A Trial of Metformin in Individuals With Fragile X Syndrome (Met) | Phase 2 | 125 | Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X-Linked, Genetic Diseases, X-Linked, Trinucleotide Repeat Expansion, Fra(X) Syndrome, Intellectual Disability, FXS, Neurobehavioral Manifestations, Sex Chromosome Disorders | METFORMIN | Open Targets' reading of its record | ClinicalTrials.gov | |
| NCT03479476 | A Trial of Metformin in Individuals With Fragile X Syndrome | Phase 2/3 | 120 | Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X Linked, Genetic Diseases, X-Linked, Trinucleotide Repeat Expansion, Fra(X) Syndrome, Intellectual Disability, FXS, Neurobehavioral Manifestations, Sex Chromosome Disorders | METFORMIN | Open Targets' reading of its record | ClinicalTrials.gov | |
| NCT00005014 | Treatment of Autism in Children and Adolescents | Phase 3 | 101 | Autistic Disorder | RISPERIDONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00160147 | Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type | Phase 3 | 60 | Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type | BIFEPRUNOX | Its record names the disease | ClinicalTrials.gov | |
| NCT01730209 | Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex | Phase 2/3 | 60 | Tuberous Sclerosis Complex, TSC Related Cognitive Disability, TSC Related Autism, TSC Related Learning Problems | EVEROLIMUS | Its record names the disease | ClinicalTrials.gov | |
| NCT01608217 | Delta-THC in Dementia | Phase 2 | 50 | Behavioural Disturbances, Pain, Dementia, Alzheimer's Dementia, Vascular Dementia | ACETAMINOPHEN, DRONABINOL | Its record names the disease | ClinicalTrials.gov | |
| NCT02942498 | Clinical Trial for Asses the Safety and Efficacy of Vitamin C and Vitamin E in Combination Versus Placebo for Treating Cognitive and Behavior Disorder in Children With Fragile X Syndrome | Phase 3 | 34 | X Fragile Syndrome | VITAMIN E | Open Targets' reading of its record | ClinicalTrials.gov | |
| NCT05818943 | Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder | Phase 1 | 24 | GRIN-related Disorders | RADIPRODIL | Its record names the disease | ClinicalTrials.gov | |
| NCT00254930 | A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children | Phase 3 | 19 | Learning Disorders, Child Behavior Disorders | RISPERIDONE | Open Targets' reading of its record | ClinicalTrials.gov | |
| NCT00347152 | Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellectual Disability | Not applicable | 18 | Epilepsy | DIVALPROEX SODIUM | Open Targets' reading of its record | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/HP_0000708/trials